Measures of body fatness and height in early and mid-to-late adulthood and prostate cancer: risk and mortality in The Pooling Project of Prospective Studies of Diet and Cancer

J. M. Genkinger*, K. Wu, M. Wang, D. Albanes, A. Black, P. A. van den Brandt, K. A. Burke, M. B. Cook, S. M. Gapstur, G. G. Giles, E. Giovannucci, G. G. Goodman, P. J. Goodman, N. Hakansson, T. J. Key, S. Mannisto, L. Le Marchand, L. M. Liao, R. J. MacInnis, M. L. NeuhouserE. A. Platz, N. Sawada, J. M. Schenk, V. L. Stevens, R. C. Travis, S. Tsugane, K. Visvanathan, L. R. Wilkens, A. Wolk, S. A. Smith-Warner

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

22 Citations (Web of Science)
3 Downloads (Pure)

Abstract

Background: Advanced prostate cancer etiology is poorly understood. Few studies have examined associations of anthropometric factors (e.g. early adulthood obesity) with advanced prostate cancer risk.

Patients and methods: We carried out pooled analyses to examine associations between body fatness, height, and prostate cancer risk. Among 830 772 men, 51 734 incident prostate cancer cases were identified, including 4762 advanced (T4/N1/M1 or prostate cancer deaths) cases, 2915 advanced restricted (same as advanced, but excluding localized cancers that resulted in death) cases, 9489 high-grade cases, and 3027 prostate cancer deaths. Cox proportional hazards models were used to calculate study-specific hazard ratios (HR) and 95% confidence intervals (CI); results were pooled using random effects models.

Results: No statistically significant associations were observed for body mass index (BMI) in early adulthood for advanced, advanced restricted, and high-grade prostate cancer, and prostate cancer mortality. Positive associations were shown for BMI at baseline with advanced prostate cancer (HR = 1.30, 95% CI = 0.95-1.78) and prostate cancer mortality (HR = 1.52, 95% CI = 1.12-2.07) comparing BMI >= 35.0 kg/m(2) with 21-22.9 kg/m(2). When considering early adulthood and baseline BMI together, a 27% higher prostate cancer mortality risk (95% CI = 9% to 49%) was observed for men with BMI = 30.0 kg/m(2) at baseline compared with BMI = 110 cm with = 1.00 with = 1.90 m with

Conclusion: Our findings suggest that height and total and central adiposity in mid-to-later adulthood, but not early adulthood adiposity, are associated with risk of advanced forms of prostate cancer. Thus, maintenance of healthy weight may help prevent advanced prostate cancer.

Original languageEnglish
Pages (from-to)103-114
Number of pages12
JournalAnnals of Oncology
Volume31
Issue number1
DOIs
Publication statusPublished - Jan 2020

Keywords

  • BMI
  • CAROTENE
  • COHORT
  • MASS INDEX
  • OBESITY
  • OVERDIAGNOSIS
  • PHYSICAL-ACTIVITY
  • POOLED ANALYSIS
  • SIZE
  • SUPPLEMENT USE
  • WEIGHT CHANGE
  • body fatness
  • height
  • pooled analysis
  • prostate cancer
  • waist
  • ANTHROPOMETRY

Cite this